eli lilly's tirzepatide is the leader in weight loss sector FDA approves for What other health conditions are
Description
Aroda VR, Ahmann A, Cariou B, Chow F, Davies MJ, Jdar E, Mehta R, Woo V, Lingvay I
M.Al-MadaniW
The recommended SAXENDA daily dose is 3 mg, with a gradual dose escalation starting at 0.6 mg per day and increasing weekly to minimize side effects
However, 82% of those on tirzepatide reached this significant clinical milestone, compared to only 67% of those on semaglutide
Clinical Trials for MASH Treatment The tirzepatide trial involved approximately 190 adults with MASH at different stages
Tirzepatides mechanism of action involves activating two naturally produced hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
